Tivicay
dolutegravir sodium
- Strength
- 50 mg/1
- Form
- Tablet, Film Coated
- Class
- Human Immunodeficiency Virus Integrase …
ST. MARY'S MEDICAL PARK PHARMACY
dolutegravir sodium and rilpivirine hydrochloride
Listed by ViiV Healthcare Company
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 49702-242 |
| FDA application | NDA210192 |
| RxNorm concept | 1989500 |
| Package sizes listed | 1 |
| Marketed since | November 2017 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
dolutegravir sodium
ST. MARY'S MEDICAL PARK PHARMACY
dolutegravir sodium
ViiV Healthcare Company
dolutegravir sodium
ViiV Healthcare Company
dolutegravir sodium
ViiV Healthcare Company
dolutegravir sodium
ViiV Healthcare Company
dolutegravir sodium and lamivudine
ViiV Healthcare Company
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.